Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

Insight Molecular Diagnostics Inc. Amortization of Intangible Assets

Insight Molecular Diagnostics Inc. (IMDX) reported Amortization of Intangible Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-10

  • Insight Molecular Diagnostics Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $0.00.
  • Insight Molecular Diagnostics Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • Insight Molecular Diagnostics Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • Insight Molecular Diagnostics Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • Insight Molecular Diagnostics Inc. amortization of intangible assets for fiscal 2025 was $7.00K, a 92.05% decline from fiscal 2024.
  • Insight Molecular Diagnostics Inc. amortization of intangible assets for fiscal 2024 was $88.00K, a 0.00% change from fiscal 2023.
  • Insight Molecular Diagnostics Inc. amortization of intangible assets for fiscal 2023 was $88.00K, a 97.62% decline from fiscal 2022.
  • Insight Molecular Diagnostics Inc. amortization of intangible assets for fiscal 2022 was $3.69M, a 9.85% increase from fiscal 2021.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$0.00
10-Q · filed 2026-08-10
$0.00
derived: sum of 3 quarters · filed 2026-08-10
$0.00
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$0.00
10-Q · filed 2026-05-13
$0.00
derived: sum of 2 quarters · filed 2026-05-13
$0.00
derived: sum of 3 quarters · filed 2026-05-13
$0.00
derived: sum of 4 quarters · filed 2026-05-13
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$0.00
derived: sum of 2 quarters · filed 2026-03-26
$0.00
derived: sum of 3 quarters · filed 2026-03-26
$7.00K
10-K · filed 2026-03-26
2025-09-30$0.00
10-Q · filed 2025-11-10
$0.00
derived: sum of 2 quarters · filed 2025-11-10
$7.00K
10-Q · filed 2025-11-10
$29.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$0.00
10-Q · filed 2025-08-11
$7.00K
10-Q · filed 2026-08-10
$29.00K
derived: sum of 3 quarters · filed 2026-08-10
$51.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$7.00K
10-Q · filed 2026-08-10
$29.00K
derived: sum of 2 quarters · filed 2026-08-10
$51.00K
derived: sum of 3 quarters · filed 2026-08-10
$73.00K
derived: sum of 4 quarters · filed 2026-08-10
2024-12-31$22.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$44.00K
derived: sum of 2 quarters · filed 2026-03-26
$66.00K
derived: sum of 3 quarters · filed 2026-03-26
$88.00K
10-K · filed 2026-03-26
2024-09-30$22.00K
10-Q · filed 2025-11-10
$44.00K
derived: sum of 2 quarters · filed 2025-11-10
$66.00K
10-Q · filed 2025-11-10
$88.00K
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$22.00K
10-Q · filed 2025-08-11
$44.00K
10-Q · filed 2025-08-11
$66.00K
derived: sum of 3 quarters · filed 2025-08-11
$88.00K
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$22.00K
10-Q · filed 2025-05-12
$44.00K
derived: sum of 2 quarters · filed 2025-05-12
$66.00K
derived: sum of 3 quarters · filed 2025-05-12
$88.00K
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$22.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
$44.00K
derived: sum of 2 quarters · filed 2025-03-24
$66.00K
derived: sum of 3 quarters · filed 2025-03-24
$88.00K
10-K · filed 2025-03-24
2023-09-30$22.00K
10-Q · filed 2024-11-12
$44.00K
derived: sum of 2 quarters · filed 2024-11-12
$66.00K
10-Q · filed 2024-11-12
$878.00K
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$22.00K
10-Q · filed 2024-08-08
$44.00K
10-Q · filed 2024-08-08
$856.00K
derived: sum of 3 quarters · filed 2024-08-08
$1.83M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$22.00K
10-Q · filed 2024-05-15
$834.00K
derived: sum of 2 quarters · filed 2024-05-15
$1.81M
derived: sum of 3 quarters · filed 2024-05-15
$2.79M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$812.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$1.79M
derived: sum of 2 quarters · filed 2024-04-16
$2.76M
derived: sum of 3 quarters · filed 2024-04-16
$3.69M
10-K · filed 2024-04-16
2022-09-30$976.00K
10-Q · filed 2023-11-09
$1.95M
derived: sum of 2 quarters · filed 2023-11-09
$2.88M
10-Q · filed 2023-11-09
$3.87M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$976.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$1.90M
10-Q · filed 2023-08-10
$2.89M
derived: sum of 3 quarters · filed 2023-08-10
$3.88M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$928.00K
10-Q · filed 2023-05-15
$1.92M
derived: sum of 2 quarters · filed 2023-05-15
$2.91M
derived: sum of 3 quarters · filed 2023-05-15
$3.98M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$990.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12
$1.98M
derived: sum of 2 quarters · filed 2023-04-12
$3.05M
derived: sum of 3 quarters · filed 2023-04-12
$3.36M
10-K · filed 2023-04-12
2021-09-30$990.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$2.06M
derived: sum of 2 quarters · filed 2022-11-10
$2.37M
10-Q · filed 2022-11-10
$2.39M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$1.38M
10-Q · filed 2022-08-12
$1.40M
derived: sum of 3 quarters · filed 2022-08-12
$1.43M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$307.00K
10-Q · filed 2022-05-12
$329.00K
derived: sum of 2 quarters · filed 2022-05-12
$351.00K
derived: sum of 3 quarters · filed 2022-05-12
$373.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$22.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$44.00K
derived: sum of 2 quarters · filed 2022-03-11
$66.00K
derived: sum of 3 quarters · filed 2022-03-11
$81.00K
10-K · filed 2022-03-11
2020-09-30$22.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$44.00K
derived: sum of 2 quarters · filed 2021-11-09
$59.00K
10-Q · filed 2021-11-09
2020-06-30$22.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$37.00K
10-Q · filed 2021-08-11
2020-03-31$15.00K
10-Q · filed 2021-05-17
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$0.00
derived: sum of 2 quarters · filed 2020-03-26
$60.00K
derived: sum of 3 quarters · filed 2020-03-26
$121.00K
10-K · filed 2020-03-26
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$60.00K
derived: sum of 2 quarters · filed 2019-11-14
$121.00K
10-Q · filed 2019-11-14
$182.00K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$121.00K
10-Q · filed 2019-08-14
$182.00K
derived: sum of 3 quarters · filed 2019-08-14
$242.00K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$61.00K
10-Q · filed 2019-05-14
$122.00K
derived: sum of 2 quarters · filed 2019-05-14
$182.00K
derived: sum of 3 quarters · filed 2019-05-14
$242.00K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$61.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$121.00K
derived: sum of 2 quarters · filed 2019-04-01
$181.00K
derived: sum of 3 quarters · filed 2019-04-01
$242.00K
10-K · filed 2019-04-01
2017-09-30$60.00K
10-Q · filed 2017-11-14
$120.00K
derived: sum of 2 quarters · filed 2018-08-14
$181.00K
10-Q · filed 2018-11-13
$242.00K
derived: sum of 4 quarters · filed 2018-08-14
2017-06-30$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$121.00K
10-Q · filed 2018-08-14
$182.00K
derived: sum of 3 quarters · filed 2018-08-14
$242.00K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$61.00K
10-Q · filed 2018-05-15
$122.00K
derived: sum of 2 quarters · filed 2018-05-15
$182.00K
derived: sum of 3 quarters · filed 2018-05-15
$242.00K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$61.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$121.00K
derived: sum of 2 quarters · filed 2018-04-02
$181.00K
derived: sum of 3 quarters · filed 2018-04-02
$242.00K
10-K · filed 2018-04-02
2016-09-30$60.00K
10-Q · filed 2017-11-14
$120.00K
derived: sum of 2 quarters · filed 2017-11-14
$181.00K
10-Q · filed 2017-11-14
$242.00K
derived: sum of 4 quarters · filed 2018-04-02
2016-06-30$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$121.00K
10-Q · filed 2017-08-14
$182.00K
derived: sum of 3 quarters · filed 2018-04-02
$242.00K
derived: sum of 4 quarters · filed 2018-04-02
2016-03-31$61.00K
10-Q · filed 2017-04-28
$122.00K
derived: sum of 2 quarters · filed 2018-04-02
$182.00K
derived: sum of 3 quarters · filed 2018-04-02
$242.00K
derived: sum of 4 quarters · filed 2018-04-02
2015-12-31$61.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$121.00K
derived: sum of 2 quarters · filed 2018-04-02
$181.00K
derived: sum of 3 quarters · filed 2018-04-02
$242.00K
10-K · filed 2018-04-02
2015-09-30$60.00K
10-Q · filed 2016-11-10
$120.00K
derived: sum of 2 quarters · filed 2016-11-10
$181.00K
10-Q · filed 2016-11-10
2015-06-30$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$121.00K
10-Q · filed 2016-08-11
2015-03-31$61.00K
10-Q · filed 2016-05-16
2014-12-31$242.00K
10-K · filed 2017-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92